Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Effect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabetes(T2DM) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating rosmarinus officinalis extract for effects on oxidative stress and inflammatory biomarkers in adults with Type 2 Diabetes Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosmarinus officinalis extract (Rosmarinus officinalis extract)

Snippet

Sponsor: Universidad Autonoma de Zacatecas | Conditions: Type 2 Diabetes Mellitus (T2DM), Oxidative Stress | Phase 1 | Status: ACTIVE_NOT_RECRUITING